ForumIAS announcing GS Foundation Program for UPSC CSE 2025-26 from 19 April. Click Here for more information.
ForumIAS Answer Writing Focus Group (AWFG) for Mains 2024 commencing from 24th June 2024. The Entrance Test for the program will be held on 28th April 2024 at 9 AM. To know more about the program visit: https://forumias.com/blog/awfg2024
News:The Council of Scientific and Industrial Research(CSIR) has sanctioned a project to develop human monoclonal antibodies as a therapy for Covid-19 in the next six months.
Facts:
- The project was approved under CSIR’s New Millennium Indian Technology Leadership Initiative(NMITLI).
- Aim: To create an alternate therapy by generating highly effective and specific human monoclonal antibodies capable of neutralising SARS-CoV2, the virus that causes Covid-19.
- Implementation: National Centre for Cell Science (NCCS), IIT-Indore and PredOmix Technologies Pvt.Ltd. with Bharat Biotech International Ltd.(BBIL) as the commercialization partner.
Additional Facts:
- NMITLI: It is the largest Public-Private partnership effort led by CSIR to catalyze innovation centred scientific and technological developments as a vehicle to attain for Indian industry a global leadership position, in selected niche areas.
- Monoclonal antibodies:These are man-made proteins that act like natural antibodies and work by identifying and binding to the virus to destroy it.
- Antibodies:It is a protective protein produced by the immune system in order to attack antigens.Antigen is a toxin or other foreign substance which induces an immune response in the body.
